|
|
||||||||
The Journal of Medical Microbiology, Vol 48, Issue 1 73-77, Copyright © 1999 by Society for General Microbiology
JOURNAL ARTICLE |
C. Dekitsch, R. Schein, E. Markopulos, B. Kuen, W. Graninger and A. Georgopoulos
Department of Infectious Diseases and Chemotherapy, University Clinic of Internal Medicine I, Vienna, Austria.
The gyrA subgenes of a quinolone-resistant Enterobacter cloacae clinical isolate (ofloxacin MIC, 16 mg/L) and of a control, E. cloacae NCTC 10005 (ofloxacin MIC, 0.03 mg/L), were amplified by polymerase chain reaction (PCR) and sequenced. The resistant isolate had mutations at the codons for amino acids 83, 89 and 90. The first of these mutations led to replacement of serine-83 by tyrosine, whereas the other mutations were silent. Digestion of PCR-amplified DNA fragments with the restriction enzyme HinfI detected mutations at the same site in gyrA in six further quinolone resistant E. cloacae isolates.
This article has been cited by other articles:
![]() |
H.-J. Linde, F. Notka, C. Irtenkauf, J. Decker, J. Wild, H.-H. Niller, P. Heisig, and N. Lehn Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae J. Antimicrob. Chemother., April 1, 2002; 49(4): 625 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Valdezate, A. Vindel, A. Echeita, F. Baquero, and R. Canto Topoisomerase II and IV Quinolone Resistance-Determining Regions in Stenotrophomonas maltophilia Clinical Isolates with Different Levels of Quinolone Susceptibility Antimicrob. Agents Chemother., March 1, 2002; 46(3): 665 - 671. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |